Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Antonio Barillà is active.

Publication


Featured researches published by Antonio Barillà.


Kidney & Blood Pressure Research | 2014

Physical Performance and Clinical Outcomes in Dialysis Patients: A Secondary Analysis of the Excite Trial

Claudia Torino; Fabio Manfredini; Davide Bolignano; Filippo Aucella; Rossella Baggetta; Antonio Barillà; Yuri Battaglia; Silvio Bertoli; Graziella Bonanno; Pietro Castellino; Daniele Ciurlino; Adamasco Cupisti; Graziella D'Arrigo; Luciano De Paola; Fabrizio Fabrizi; Pasquale Fatuzzo; Giorgio Fuiano; Luigi Lombardi; Gaetano Lucisano; Piergiorgio Messa; Renato Rapanà; Francesco Rapisarda; Stefania Rastelli; Lisa Rocca-Rey; Chiara Summaria; Alessandro Zuccalà; Giovanni Tripepi; Luigi Catizone; Carmine Zoccali; Francesca Mallamaci

Background/Aims: Scarce physical activity predicts shorter survival in dialysis patients. However, the relationship between physical (motor) fitness and clinical outcomes has never been tested in these patients. Methods: We tested the predictive power of an established metric of motor fitness, the Six-Minute Walking Test (6MWT), for death, cardiovascular events and hospitalization in 296 dialysis patients who took part in the trial EXCITE (ClinicalTrials.gov Identifier: NCT01255969). Results: During follow up 69 patients died, 90 had fatal and non-fatal cardiovascular events, 159 were hospitalized and 182 patients had the composite outcome. In multivariate Cox models - including the study allocation arm and classical and non-classical risk factors - an increase of 20 walked metres during the 6MWT was associated to a 6% reduction of the risk for the composite end-point (P=0.001) and a similar relationship existed between the 6MWT, mortality (P<0.001) and hospitalizations (P=0.03). A similar trend was observed for cardiovascular events but this relationship did not reach statistical significance (P=0.09). Conclusions: Poor physical performance predicts a high risk of mortality, cardiovascular events and hospitalizations in dialysis patients. Future studies, including phase-2 EXCITE, will assess whether improving motor fitness may translate into better clinical outcomes in this high risk population.


Blood Purification | 2006

Dialysis-related genotoxicity: sister chromatid exchanges and DNA lesions in T and B lymphocytes of uremic patients. Genomic damage in patients on hemodiafiltration.

Michele Buemi; Fulvio Floccari; Chiara Costa; Chiara Caccamo; N. Belghity; Susanna Campo; F. Pernice; G. Bonvissuto; Giuseppe Coppolino; Antonio Barillà; Manila Criseo; Eleonora Crascì; Lorena Nostro; Adriana Arena

Background/Aims: Patients with chronic renal failure show the presence of massive oxidative genome damage but the role played by dialysis is still a controversial issue. The aim of our study was to verify the genomic damage in B- and T-lymphocyte subpopulations of uremic patients after a single hemodiafiltration session. Methods: We enrolled 30 patients on maintenance acetate-free biofiltration and 25 age-matched healthy volunteers and studied chromosomal alterations. Results: Our data show that the basal levels of DNA damage, the number of sister chromatid exchanges and basal high-frequency cells levels are significantly higher in patients on hemodiafiltration than in controls and in T lymphocytes than in B cells. Conclusions: These findings suggest that hemodialytic treatment could represent a potential source of damage, maybe through the oxidative action of the extracorporeal circuit components, which might explain the well-known T-specific immunodeficiency correlated with uremia.


Journal of The American Society of Nephrology | 2017

Exercise in Patients on Dialysis: A Multicenter, Randomized Clinical Trial.

Fabio Manfredini; Francesca Mallamaci; Graziella D’Arrigo; Rossella Baggetta; Davide Bolignano; Claudia Torino; Nicola Lamberti; Silvio Bertoli; Daniele Ciurlino; Lisa Rocca-Rey; Antonio Barillà; Yuri Battaglia; Renato Rapanà; Alessandro Zuccalà; Graziella Bonanno; Pasquale Fatuzzo; Francesco Rapisarda; Stefania Rastelli; Fabrizio Fabrizi; Piergiorgio Messa; Luciano De Paola; Luigi Lombardi; Adamasco Cupisti; Giorgio Fuiano; Gaetano Lucisano; Chiara Summaria; Michele Felisatti; Enrico Pozzato; Anna Maria Malagoni; Pietro Castellino

Previous studies have suggested the benefits of physical exercise for patients on dialysis. We conducted the Exercise Introduction to Enhance Performance in Dialysis trial, a 6-month randomized, multicenter trial to test whether a simple, personalized walking exercise program at home, managed by dialysis staff, improves functional status in adult patients on dialysis. The main study outcomes included change in physical performance at 6 months, assessed by the 6-minute walking test and the five times sit-to-stand test, and in quality of life, assessed by the Kidney Disease Quality of Life Short Form (KDQOL-SF) questionnaire. We randomized 296 patients to normal physical activity (control; n=145) or walking exercise (n=151); 227 patients (exercise n=104; control n=123) repeated the 6-month evaluations. The distance covered during the 6-minute walking test improved in the exercise group (mean distance±SD: baseline, 328±96 m; 6 months, 367±113 m) but not in the control group (baseline, 321±107 m; 6 months, 324±116 m; P<0.001 between groups). Similarly, the five times sit-to-stand test time improved in the exercise group (mean time±SD: baseline, 20.5±6.0 seconds; 6 months, 18.2±5.7 seconds) but not in the control group (baseline, 20.9±5.8 seconds; 6 months, 20.2±6.4 seconds; P=0.001 between groups). The cognitive function score (P=0.04) and quality of social interaction score (P=0.01) in the kidney disease component of the KDQOL-SF improved significantly in the exercise arm compared with the control arm. Hence, a simple, personalized, home-based, low-intensity exercise program managed by dialysis staff may improve physical performance and quality of life in patients on dialysis.


Nephrology | 2004

QTc interval and QTc dispersion during haemodiafiltration

Fulvio Floccari; Emanuele Aloisi; Lorena Nostro; Chiara Caccamo; Alessandra Crisafulli; Antonio Barillà; Carmela Aloisi; Adolfo Romeo; Francesco Corica; Riccardo Ientile; Nicola Frisina; Michele Buemi

Background and Aim:  Our aim was to evaluate QTc interval and QTc dispersion in 27 end‐stage renal disease (ESRD) patients undergoing Acetate Free Biofiltration (AFB) in order to ascertain any correlations between the electrrocardiographic (ECG) parameters, serum Na+, K+, Ca++, Mg++ and intraerythrocytic Mg++ (Mg++e) concentrations. All measures were made at t0 (session beginning), t1 (first hour), t2 (second hour), t3 (third hour), and t4 (session end).


Kidney & Blood Pressure Research | 2014

Fitness for Entering a Simple Exercise Program and Mortality: A Study Corollary to the Exercise Introduction to Enhance Performance in Dialysis (Excite) Trial

Rossella Baggetta; Davide Bolignano; Claudia Torino; Fabio Manfredini; Filippo Aucella; Antonio Barillà; Yuri Battaglia; Silvio Bertoli; Graziella Bonanno; Pietro Castellino; Daniele Ciurlino; Adamasco Cupisti; Graziella D'Arrigo; Luciano De Paola; Fabrizio Fabrizi; Pasquale Fatuzzo; Giorgio Fuiano; Luigi Lombardi; Gaetano Lucisano; Piergiorgio Messa; Renato Rapanà; Francesco Rapisarda; Stefania Rastelli; Lisa Rocca-Rey; Chiara Summaria; Alessandro Zuccalà; Samar Abd ElHafeez; Giovanni Tripepi; Luigi Catizone; Francesca Mallamaci

Background/Aims: In this corollary analysis of the EXCITE study, we looked at possible differences in baseline risk factors and mortality between subjects excluded from the trial because non-eligible (n=216) or because eligible but refusing to participate (n=116). Methods: Baseline characteristics and mortality data were recorded. Survival and independent predictors of mortality were assessed by Kaplan-Meier and Cox regression analyses. Results: The incidence rate of mortality was higher in non-eligible vs. eligible non-randomized patients (21.0 vs. 10.9 deaths/100 persons-year; P<0.001). The crude excess risk of death in non-eligible patients (HR 1.96; 95% CI 1.36 to 2.77; P<0.001) was reduced after adjustment for risk factors which differed in the two cohorts including age, blood pressure, phosphate, CRP, smoking, diabetes, triglycerides, cardiovascular comorbidities and history of neoplasia (HR 1.60; 95% CI 1.10 to 2.35; P=0.017) and almost nullified after including in the same model also information on deambulation impairment (HR 1.16; 95% CI 0.75 to 1.80; P=0.513). Conclusions: Deambulation ability mostly explains the difference in survival rate in non-eligible and eligible non-randomized patients in the EXCITE trial. Extending data analyses and outcome reporting also to subjects not taking part in a trial may be helpful to assess the representability of the study population.


Renal Failure | 2007

Aquaporin-2 (AQP2) Urinary Excretion and Assumption of Water with Different Mineral Content in Healthy Subjects

Michele Buemi; Davide Bolignano; Giuseppe Coppolino; Giuseppe Di Pasquale; Vincenzo Cosentini; Susanna Campo; Antonio Barillà; Carmela Aloisi

The aquaporin-2 (AQP2) plays a key role in AVP-induced absorption of water, and its urinary excretion is related to its function. We aimed to test if the assumption of water with different mineral content can modify the expression of AQP2, leading to a change in AQP2 urinary concentration, in 20 healthy young subjects. Each subject received an oral water load (LM or HM) of 250 mL/hour for four hours, and several variables were measured. Plasmatic osmolality after water assumption was significantly reduced with no differences after the low (LM) or the high mineral (HM) water load. Urinary osmolality and plasmatic vasopressin concentration were significantly reduced after an assumption of both kinds of water. However, serum vasopressin was lower after HM water assumption than after LM. AQP2 urinary excretion was significantly reduced after water assumption with respect to the basal level and it was lower after LM than after HM water assumption. The different mineral content of water was investigated as a factor contributing to the development of hypertension. Considering that AQP2 can play a role in pathogenesis of hypertension, our demonstration that AVP-mediated AQP2 urinary excretion is strictly influenced by the consumption of water with different mineral content suggests a new, interesting field of investigation related to the link between blood pressure alterations and nutritional habits.


Nephrology Dialysis Transplantation | 2005

The effect of two different protocols of potassium haemodiafiltration on QT dispersion

Michele Buemi; Emanuele Aloisi; Giuseppe Coppolino; Saverio Loddo; Eleonora Crascì; Carmela Aloisi; Antonio Barillà; Vincenzo Cosentini; Lorena Nostro; Chiara Caccamo; Fulvio Floccari; Adolfo Romeo; Nicola Frisina; Diana Teti


European Journal of Pharmacology | 2006

Chromosomal damage and atherosclerosis. A protective effect from simvastatin.

Franco Pernice; Fulvio Floccari; Chiara Caccamo; Nadia Belghity; Stefania Mantuano; Maria Elisa Pacilè; Adolfo Romeo; Lorena Nostro; Antonio Barillà; Eleonora Crascì; Nicola Frisina; Michele Buemi


Journal of Renal Nutrition | 2007

Caffeine and the Kidney: What Evidence Right Now?

Davide Bolignano; Giuseppe Coppolino; Antonio Barillà; Susanna Campo; Manila Criseo; Donatella Tripodo; Michele Buemi


Medicinal Research Reviews | 2005

Statins in nephrotic syndrome : A new weapon against tissue injury

Michele Buemi; Lorena Nostro; Eleonora Crascì; Antonio Barillà; Vincenzo Cosentini; Carmela Aloisi; Tito Sofi; Susanna Campo; Nicola Frisina

Collaboration


Dive into the Antonio Barillà's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge